Desotop Gel0.05%
Type:15gm tube
Generic Name:Desonide 0.05% Topical
Manufacturer:ACI Limited
Price:৳50.34
Indication
Psoriasis, Eczema, Contact dermatitis, Corticosteroid-responsive dermatoses, Seborrheic dermatitis
Adult Dose
Topical/Cutaneous Corticosteroid-responsive dermatoses Adult: Apply sparingly onto the affected areas 2-4 times/day. Discontinue therapy when control is achieved.
Contraindication
Hypersensitivity to any of the components. Primary infective skin conditions.
Mode of Action
Desonide is a corticosteroid used mainly for its glucocorticoid activity in the treatment of various skin disorders.
Precaution
Caution when using in paed patients. Evaluate periodically for evidence of HPA-axis suppression. In the event of secondary infections use appropriate antibiotics and discontinue topical steroid. Pregnancy and lactation. Lactation: excretion in milk unknown; use with caution
Side Effect
Burning, itching, irritation, scaling, folliculitis, hypertrichosis, contact dermatitis, skin peeling, transient erythema. Skin atrophy, Striae, Acneform lesions, Pigmentation changes
Pregnancy Category Note
Pregnancy There are no available data on use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes Lactation There are no data on presence in human or animal milk, effects on breastfed infant, or on milk production; unknown whether topical administration could result in sufficient systemic absorption to produce detectable quantities in human milk; developmental and health benefits should be considered along with mother’s clinical need for therapy and any potential adverse effects on breastfed infant from therapy or from the underlying maternal condition To minimize potential exposure to breastfed infant via breast milk, use on smallest area of skin and for shortest duration possible while breastfeeding; advise breastfeeding women to wash off any amount that may have been applied to nipple and areola prior to breastfeeding to avoid direct infant exposure